When all else failed, a doctor first prescribed her Ozempic (Semaglutide) and then Mounjaro (Tirzepatide), an injectable drug originally ... At 21, Charvee was diagnosed with Polycystic Ovary Syndrome ...

Adults with type 1 diabetes had greater declines in HbA1c and body weight 1 year after being prescribed semaglutide or tirzepatide. Randomized controlled trials are needed to assess efficacy and ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture knockoff versions of Eli Lilly's tirzepatide while a lawsuit plays out.

Polycystic Ovary Syndrome (PCOS) affects millions of women worldwide, causing hormonal imbalances that impact fertility. Emotional and physical challenges often accompany a PCOS diagnosis ...

Larger outsourcing facilities, which are FDA-regulated and can create prescription-specific compounded drugs as well as bulk orders, must cease compounding, distributing or dispensing tirzepatide ...

Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions. This association is being called “Ozempic blindness.” Experts are not entirely clear why ...

PCOS is a very debilitating health condition that impacts women. The key features of PCOS are hormonal imbalance, irregular menstrual cycles, ovarian cysts, insulin resistance, fertility issues.

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions. This association is being called “Ozempic blindness.” Experts are not entirely clear why ...

Two recent tools in the battle for weight loss have been showing incredible results: Semaglutide and Tirzepatide. Stephanie Davison from Skin Envy Non-Surgical Weight Loss Center, and Registered ...

Metformin is often prescribed to help reduce PCOS symptoms, but how does it work, and what happens when you take it? Madeleine Spencer tried it, and there were some surprising effects Chances are ...

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...